stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Phathom Pharmaceuticals IncPHAT
$5.742.96%-0.175
Pre-mercato: 5.80+0.06 +1.05%

Phathom Pharmaceuticals Inc (PHAT)

Date: 2026-11-03 16:00O: 5.92H: 6.11L: 5.50C: 5.74Vol: 2.163M
Precedente Chiudi:
$5.92
Aprire:
$5.92
Volume 24 ore:
2,162,820
Volume relativo:
0.93
Capitalizzazione di mercato:
$466.61M
Reddito:
$204.89M
Utile/perdita netta:
-$157.30M
Rapporto P/E:
-
EPS:
-$2.11
Flusso di cassa netto:
-$97.76M
1W Prestazione:
-8.60%
1M Prestazione:
-17.05%
6M Prestazione:
-55.40%
1Y Prestazione:
-57.45%
Intervallo 1D:
$0.00$0.00
Intervallo di 1 settimana:
$5.50$7.00
Portata 52W:
$5.02$18.31

Profilo aziendale di Phathom Pharmaceuticals Inc (PHAT)

Nome
Phathom Pharmaceuticals Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
(877) 742-8466
Indirizzo
100 CAMPUS DRIVE,, FLORHAM PARK, NJ, USA
Dipendente
371
X
-
Prossima data di guadagno
null
Ultimi documenti SEC
SEC
Discussioni di PHAT su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Phathom Pharmaceuticals Inc Azioni (PHAT) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-09-09IniziatoLeerink PartnersMarket Perform
2026-03-27AggiornamentoBarclaysEqual Weight → Overweight
2025-12-12IniziatoRaymond JamesStrong Buy
2025-12-09IniziatoBarclaysEqual Weight

Phathom Pharmaceuticals Inc Azioni (PHAT) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022FY 2021
Data di fine periodo2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)175.1155.250.680.000.00
Cost of revenue USD (M)22.607.970.17--
Gross profit USD (M)152.5147.280.52--
Research and development USD (M)32.7834.0849.9071.4472.34
Operating expenses USD (M)312.50324.75167.83172.44135.08
Operating income USD (M)-159.99-277.47-167.31-172.44-135.08
Income before tax USD (M)-221.25--201.59-197.72-143.88
Income tax expense USD (M)0.000.000.000.000.00
Net income USD (M)-221.25-334.33-201.59-197.72-143.88
Basic EPS USD/shares-3.03-5.29-3.93-5.05-
Diluted EPS USD/shares-3.03-5.29-3.93-5.05-
Basic weighted shares shares (M)72.9263.1851.2939.12-
Diluted weighted shares shares (M)72.9263.1851.2939.12-
Selling, general and administrative USD (M)279.72290.66117.93--

Phathom Pharmaceuticals Inc Azioni (PHAT) insider trading

  • Parikh AsitMay 20 '26
    Director
    Transazione
    Option Exercise
    Costo
    $4.95
    #Azioni
    17,500
    Valore ($)
    86,625
    #Azioni Totale
    52,122
  • Parikh AsitJan 13 '26
    Director
    Transazione
    Option Exercise
    Costo
    $10.30
    #Azioni
    8,750
    Valore ($)
    90,125
    #Azioni Totale
    131,000
  • Parikh AsitDec 19 '25
    Director
    Transazione
    Option Exercise
    Costo
    $10.30
    #Azioni
    8,750
    Valore ($)
    90,125
    #Azioni Totale
    122,250
  • Basta Steven LNov 28 '25
    President and CEO
    Transazione
    Option Exercise
    Costo
    $0.00
    #Azioni
    90,000
    Valore ($)
    0
    #Azioni Totale
    131,625
  • Principal Accounting Officer
    Transazione
    Sale
    Costo
    $13.51
    #Azioni
    524
    Valore ($)
    7,079
    #Azioni Totale
    47,407
  • President and CEO
    Transazione
    Option Exercise
    Costo
    $0.00
    #Azioni
    90,000
    Valore ($)
    0
    #Azioni Totale
    90,000
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Parikh AsitDirectorMay 20 '26Option Exercise$4.9517,50086,62552,122
Parikh AsitDirectorJan 13 '26Option Exercise$10.308,75090,125131,000
Parikh AsitDirectorDec 19 '25Option Exercise$10.308,75090,125122,250
Basta Steven LPresident and CEONov 28 '25Option Exercise$0.0090,0000131,625
Breedlove Robert CharlesPrincipal Accounting OfficerNov 03 '25Sale$13.515247,07947,407
Basta Steven LPresident and CEOOption Exercise$0.0090,000090,000

Phathom Pharmaceuticals Inc Borsa (PHAT) Ultime notizie

Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 29, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 23, 2026
Oct 20, 2026
Oct 20, 2026
Oct 19, 2026
Oct 19, 2026
Oct 14, 2026
Oct 14, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 02, 2026
Oct 02, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 12, 2026
Sep 12, 2026
Sep 10, 2026
Sep 10, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 05, 2026
Sep 05, 2026
Sep 04, 2026
Sep 04, 2026
Sep 03, 2026
Sep 03, 2026
Sep 02, 2026
Sep 02, 2026
Sep 01, 2026
Sep 01, 2026

Simile a PHAT